Uriblo 40 Number 140 (Paramesh Banerji Life Sciences LLC)
Welcome to the PulseAid listing for the Uriblo 40 Number 140 drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Paramesh Banerji Life Sciences LLC |
NON-PROPRIETARY NAME: | Arnica montana, Cantharis |
SUBSTANCE NAME: | ARNICA MONTANA; LYTTA VESICATORIA |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2015-02-21 |
END MARKETING DATE: | 0000-00-00 |
Uriblo 40 Number 140 HUMAN OTC DRUG Details:
Item Description | Uriblo 40 Number 140 from Paramesh Banerji Life Sciences LLC |
LABELER NAME: | Paramesh Banerji Life Sciences LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200; 30([hp_C]/1; [hp_C]/1) |
START MARKETING DATE: | 2015-02-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69152-0140_0f993d38-7b4a-143c-e054-00144ff8d46c |
PRODUCT NDC: | 69152-0140 |
APPLICATION NUMBER: | |
Other ARNICA MONTANA; LYTTA VESICATORIA Pharmaceutical Manufacturers / Labelers: